Abbott leading race to treat blocked arteries below the knee effectively, says analyst
Abbott recently announced a clinical trial of its drug-eluting stent, which it says provides an effective treatment for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Sep 20
Abbott recently announced a clinical trial of its drug-eluting stent, which it says provides an effective treatment for…
10 Sep 20
Venus Medtech and Venus Haoyue Medtech will jointly provide total treatment solutions for heart valve diseases from the…
09 Sep 20
Kardium is a medical solutions company that has developed an advanced system for the treatment of atrial fibrillation,…
04 Sep 20
The LIFE-BTK trial is designed to evaluate Abbott’s new drug-eluting resorbable scaffold (DRS), for the treatment of blocked…
02 Sep 20
Baylis Medical is a leader in the development and commercialization of innovative medical devices in the fields of…
01 Sep 20
Chocolate Touch drug-coated balloon is the world's first balloon catheter that combines therapeutic agent delivery with the next…
31 Aug 20
Both STOP AF First trial and the Cryo-FIRST trial found that Medtronic’s cryoablation system is superior to AAD…
28 Aug 20
The CARTO 3 platform is strengthened with the CARTO PRIME Mapping Module for enhanced mapping capabilities to reduce…
28 Aug 20
Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices…
27 Aug 20
The system is now being used to treat patients with Atrial Fibrillation (AF), a common heart rhythm disorder,…